期刊文献+

奥扎格雷钠治疗急性脑梗死的疗效观察 被引量:31

Observation of therapeutic effeets of sodium ozagrel on acute cerebral infarction
下载PDF
导出
摘要 目的 观察奥扎格雷钠治疗急性脑梗死的临床疗效。方法 选用一般情况具有可比性的急性脑梗死患者 ,随机分成两组 ,治疗组 5 0例 ,对照组 45例。治疗组用奥扎格雷钠注射液 80mg加生理盐水 2 5 0ml静滴 ,1/d ;对照组给予低分子右旋糖酐 5 0 0ml+复方丹参 2 0ml静滴 ,1次 /d ,两组疗程均为 14d。结果 治疗组总有效率 92 % ,对照组 78% ;两组治疗前神经功能缺损评分无显著差异 ((P >0 0 5 )。治疗 14d后两组评分较前明显下降 ,但以奥扎格雷钠治疗组下降显著 ,治疗后两组平均评分有显著差异性 (P <0 0 1)。结论 表明奥扎格雷钠治疗急性脑梗死是安全有效的 ,使急性脑梗死患者临床症状显著改善。 Objective To observe the clinical efficacy of sodium ozagrel in the treatment of acute cerebral infarction. Methods Two groups of patients who had acute cerebral infarctions with comparative conditions were randomly divided into a therapeutic group(50 cases)and a control group(45cases).The patients of the therapeutic group were given sodium ozagrel 80mg dissolved in 0.9% sodium chloride injection 250ml once a day intravenously.and in the control group were given codanshen 20ml in low molecular weight dextran 500ml once a day. Two groups of patients all had 14days one course of treatment.Rusults The effective results in the theraprutic group were 92%while those in the control group were 77%.and the nervous function victim comparison has no distinct difference(p>0.05)before cure.the comparison of two groups descent more distinct than before after 14 days cure,but the sodium ozagrel group was more great.the average comparison of two groups has great distinct difference (p<0.01) after cure.Conclusion The therapeutic effects of sodium ozagrelwere obvious in the treatment of acute cerebral infarction.The clinical symptoms were singificantly improved in the patients of the therapeuti group.
出处 《实用神经疾病杂志》 2005年第1期6-7,共2页
  • 相关文献

参考文献5

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 2[2]Mori E,Tabuchi M,Yamadori A. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery[J].Stroke,1988,19:802~806
  • 3史玉泉.实用神经病学[M].上海:上海科学技术出版社,1994.649-670.
  • 4丁煜.抗凝药.合成药,生化药[J].照射医学.制剂分册,1990,3:11-11.
  • 5[5]Markus,Barley J,Lunt R,et al.Angiotensin-converting enzymegenedeletion polymorphism:a new risk factor for lacunar stroke but not carotid atheroma[J].Storke,1995,26:1329~1333

共引文献33288

同被引文献103

引证文献31

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部